Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 28.82 USD -2.21% Market Closed
Market Cap: 926m USD

Intrinsic Value

The intrinsic value of one COLL stock under the Base Case scenario is 60.43 USD. Compared to the current market price of 28.82 USD, Collegium Pharmaceutical Inc is Undervalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

COLL Intrinsic Value
60.43 USD
Undervaluation 52%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Collegium Pharmaceutical Inc

Valuation History Unavailable

Historical valuation for COLL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Collegium Pharmaceutical Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Collegium Pharmaceutical Inc

Current Assets 527.6m
Cash & Short-Term Investments 197.8m
Receivables 228.7m
Other Current Assets 101.1m
Non-Current Assets 1.1B
PP&E 19.4m
Intangibles 986.7m
Other Non-Current Assets 97.8m
Efficiency

Free Cash Flow Analysis
Collegium Pharmaceutical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Collegium Pharmaceutical Inc

Revenue
664.3m USD
Cost of Revenue
-281.1m USD
Gross Profit
383.2m USD
Operating Expenses
-252.4m USD
Operating Income
130.8m USD
Other Expenses
-86.9m USD
Net Income
43.9m USD
Fundamental Scores

COLL Profitability Score
Profitability Due Diligence

Collegium Pharmaceutical Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Operating Income
ROIC is Increasing
53/100
Profitability
Score

Collegium Pharmaceutical Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

COLL Solvency Score
Solvency Due Diligence

Collegium Pharmaceutical Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Positive Net Debt
High D/E
25/100
Solvency
Score

Collegium Pharmaceutical Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COLL Price Targets Summary
Collegium Pharmaceutical Inc

Wall Street analysts forecast COLL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COLL is 43.66 USD with a low forecast of 36.36 USD and a high forecast of 52.5 USD.

Lowest
Price Target
36.36 USD
26% Upside
Average
Price Target
43.66 USD
51% Upside
Highest
Price Target
52.5 USD
82% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Collegium Pharmaceutical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for COLL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

COLL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one COLL stock?

The intrinsic value of one COLL stock under the Base Case scenario is 60.43 USD.

Is COLL stock undervalued or overvalued?

Compared to the current market price of 28.82 USD, Collegium Pharmaceutical Inc is Undervalued by 52%.

Back to Top